UMARY hyaluronic acid supplement recalled for undeclared drugs
FDA laboratory analysis found the UMARY Acido Hialuronico supplement contains undeclared dexamethasone, diclofenac and omeprazole, which are not listed on the label. The product was also marketed without an approved NDA or ANDA. About 15 bottles were distributed nationwide under the IBeautiStore.com brand.
From the FDA notice · Read the official notice ↗
What to do
- Stop using the product and don't give it to others.
- Check whether your bottle is labeled "UMARY Acido Hialuronico" or "New Hyaluronic Acid 850mg Sealed 30 Caps" with 30 capsules of 850 mg.
- The notice doesn't say how to get a refund or replacement; contact IBeautiStore.com or where you bought it.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- UMARY Acido Hialuronico, also known as: "New Hyaluronic Acid 850mg Sealed 30 Caps", Suplemento Alimenticio, Contenido Neto: 30 capletas de 850 mg.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 15 bottles
- Illnesses reported
- None reported
- Manufactured in
- 3042 Route 22 # 38, Dover Plains, New York, United States
- Classification
- Class I
- Recall number
- D-0189-2027
In the FDA's words
- Description
- UMARY Acido Hialuronico, also known as: "New Hyaluronic Acid 850mg Sealed 30 Caps", Suplemento Alimenticio, Contenido Neto: 30 capletas de 850 mg. Marketed without approved NDA/ANDA- FDA laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole. Lots 241209P3, 250129P3, 250508P3, 25112P3 & 260511P3, any Expiration Date between 9/26 and 8/28. Distribution: USA Nationwide Affected quantity: 15 bottles
- Hazard
- Marketed without approved NDA/ANDA- FDA laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.